Short duration: The 8-week length provides only short-term insights, limiting conclusions about long-term cardiometabolic effects
Patients beginning at lower doses experience appetite changes gradually, while those starting at higher initial doses may notice effects more quickly
Men with organic ED (vascular, neurogenic) should not expect complete resolution from weight loss alone
Keep a written record of when you administer each dose, including the date and time
All but one of the studies included in the systematic review did not provide sex-disaggregated data, limiting the interpretation of the impact of GLP-1 RAs on the measured outcomes
Retatrutide is an investigational triple incretin receptor agonist (GLP-1, GIP, and glucagon) not yet approved by the MHRA or EMA